Literature DB >> 27570418

Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Mahmoud Fathy Dondeti1, Eman Anwar El-Maadawy1, Roba Mohamed Talaat1.   

Abstract

Hepatocellular carcinoma (HCC) is a primary liver cancer, which is one of the most prevalent cancers among humans. Many factors are involved in the liver carcinogenesis as lifestyle and environmental factors. Hepatitis virus infections are now recognized as the chief etiology of HCC; however, the precise mechanism is still enigmatic till now. The inflammation triggered by the cytokine-mediated immune response, was reported to be the closest factor of HCC development. Cytokines are immunoregulatory proteins produced by immune cells, functioning as orchestrators of the immune response. Genes of cytokines and their receptors are known to be polymorphic, which give rise to variations in their genes. These variations have a great impact on the expression levels of the secreted cytokines. Therefore, cytokine gene polymorphisms are involved in the molecular mechanisms of several diseases. This piece of work aims to shed much light on the role of cytokine gene polymorphisms as genetic host factor in hepatitis related HCC.

Entities:  

Keywords:  Cytokines; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27570418      PMCID: PMC4974580          DOI: 10.3748/wjg.v22.i30.6800

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  225 in total

Review 1.  The extent and analysis of cytokine and cytokine receptor gene polymorphism.

Authors:  Leigh J Keen
Journal:  Transpl Immunol       Date:  2002-08       Impact factor: 1.708

2.  Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism.

Authors:  Natalia Paladino; Hugo Fainboim; Graciela Theiler; Teresa Schroder; Alberto Eduardo Muñoz; Ana Claudia Flores; Omar Galdame; Leonardo Fainboim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Up-regulation of IL-18 by interferon alpha-2b/ribavirin combination therapy induces an anti-viral effect in patients with chronic hepatitis C.

Authors:  Kazumoto Murata; Norihiko Yamamoto; Tomoyuki Kawakita; Yukiko Saito; Yutaka Yamanaka; Kazushi Sugimoto; Katsuya Shiraki; Takeshi Nakano; Yukihiko Tameda
Journal:  Hepatogastroenterology       Date:  2005 Mar-Apr

4.  Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads.

Authors:  L M Taylor; L M Khachigian
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  IL-16 activates the SAPK signaling pathway in CD4+ macrophages.

Authors:  S Krautwald
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

6.  Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.

Authors:  C F Terry; V Loukaci; F R Green
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

Review 7.  Interleukin-16.

Authors:  W W Cruikshank; H Kornfeld; D M Center
Journal:  J Leukoc Biol       Date:  2000-06       Impact factor: 4.962

Review 8.  Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease.

Authors:  L J Abraham; K M Kroeger
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

9.  Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells.

Authors:  Nicole Phoa; Bernd Epe
Journal:  Carcinogenesis       Date:  2002-03       Impact factor: 4.944

10.  IL-6 regulates neutrophil trafficking during acute inflammation via STAT3.

Authors:  Ceri A Fielding; Rachel M McLoughlin; Louise McLeod; Chantal S Colmont; Meri Najdovska; Dianne Grail; Matthias Ernst; Simon A Jones; Nicholas Topley; Brendan J Jenkins
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

View more
  13 in total

1.  The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.

Authors:  Linghong Guo; Honghong Ren; Lutong Pu; Xingyu Zhu; Yin Liu; Xuelei Ma
Journal:  Cancer Manag Res       Date:  2020-08-13       Impact factor: 3.989

2.  Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV).

Authors:  Mahmoud F Dondeti; Mohamed S Abdelkhalek; Hosam M El-Din Elezawy; Walaa F Alsanie; Bassem M Raafat; Amira M Gamal-Eldeen; Roba M Talaat
Journal:  J Appl Biomed       Date:  2022-01-12       Impact factor: 1.797

Review 3.  Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma.

Authors:  Yue Chen; Haoyue Hu; Xianglei Yuan; Xue Fan; Chengda Zhang
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

4.  Activation of the Toll‑like receptor 2 signaling pathway inhibits the proliferation of HCC cells in vitro.

Authors:  Yi Chen; Zuxiong Huang; Xuzheng Chen; Hanhui Ye
Journal:  Oncol Rep       Date:  2019-09-27       Impact factor: 3.906

5.  Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis.

Authors:  Yi Quan; Jun Yang; Tao Qin; Yufang Hu
Journal:  World J Surg Oncol       Date:  2019-12-12       Impact factor: 2.754

Review 6.  Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis.

Authors:  Su Yeon An; Anca D Petrescu; Sharon DeMorrow
Journal:  Front Pharmacol       Date:  2021-03-24       Impact factor: 5.810

7.  Association of interleukin-18 genotypes (-607C > A) and (-137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinoma.

Authors:  Taqveema Ali; Roli Saxena; Isha Rani; Renuka Sharma; Deepti More; Rajendra Ola; Stuti Agarwal; Yogesh Kumar Chawla; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2021-06-24       Impact factor: 3.396

8.  Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis.

Authors:  Zhi-Gang Gong; Weijie Zhao; Jianbing Zhang; Xi Wu; Jing Hu; Guo-Chang Yin; Yong-Jiang Xu
Journal:  Oncotarget       Date:  2017-07-10

9.  Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis.

Authors:  Marwa O El-Derany
Journal:  Biology (Basel)       Date:  2020-04-09

10.  Interleukin-6 polymorphisms in HCC patients chronically infected with HCV.

Authors:  Faisal Adnan; Najeeb Ullah Khan; Aqib Iqbal; Ijaz Ali; Arnolfo Petruzziello; Rocco Sabatino; Annunziata Guzzo; Giovanna Loquercio; Gerardo Botti; Sanaullah Khan; Muhammad Naeem; Muhammad Ismail Khan
Journal:  Infect Agent Cancer       Date:  2020-04-01       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.